Table 3 The association of SPP1 expression and the survival in cancer patients
Cancer | N | Cox p-value | HR | Endpoint | Dataset | Probe ID |
|---|---|---|---|---|---|---|
Bladder | 165 | 0.027573 | 1.24 | Disease Specific Survival | GSE13507 | ILMN_1651354 |
Blood | 79 | 0.034027 | 1.38 | Overall Survival | GSE12417-GPL570 | 209875_s_at |
Brain | 50 | 0.011310 | 1.32 | Overall Survival | MGH-glioma | 34342_s_at |
50 | 0.014265 | 1.27 | Overall Survival | MGH-glioma | 2092_s_at | |
74 | 0.001376 | 2.44 | Overall Survival | GSE4412-GPL96 | 209875_s_at | |
Breast | 155 | 0.049236 | 0.83 | Overall Survival | GSE9893 | 400 |
286 | 0.026936 | 1.27 | Distant Metastasis Free Survival | GSE2034 | 209875_s_at | |
159 | 0.001286 | 1.71 | Overall Survival | GSE1456-GPL96 | 209875_s_at | |
159 | 0.011567 | 1.5 | Relapse Free Survival | GSE1456-GPL96 | 209875_s_at | |
159 | 0.005257 | 1.73 | Disease Specific Survival | GSE1456-GPL96 | 209875_s_at | |
198 | 0.032468 | 1.22 | Overall Survival | GSE7390 | 209875_s_at | |
Colorectal | 62 | 0.0411806 | 1.46 | Overall Survival | GSE12945 | 209875_s_at |
177 | 0.0077045 | 1.33 | Disease Specific Survival | GSE17536 | 209875_s_at | |
177 | 0.0332507 | 1.34 | Overall Survival | GSE17536 | 1568574_x_at | |
177 | 0.0144318 | 1.45 | Disease Specific Survival | GSE17536 | 1568574_x_at | |
177 | 0.0202343 | 1.23 | Overall Survival | GSE17536 | 209875_s_at | |
145 | 0.00140364 | 1.56 | Disease Free Survival | GSE17536 | 209875_s_at | |
226 | 0.00135618 | 1.40 | Disease Free Survival | GSE14333 | 209875_s_at | |
49 | 0.030453 | 1.45 | Disease Specific Survival | GSE17537 | 1568574_x_at | |
55 | 0.0163347 | 1.31 | Overall Survival | GSE17537 | 209875_s_at | |
55 | 0.00149779 | 1.52 | Disease Free Survival | GSE17537 | 209875_s_at | |
49 | 0.0310856 | 1.38 | Disease Specific Survival | GSE17537 | 209875_s_at | |
55 | 0.000282164 | 1.72 | Disease Free Survival | GSE17537 | 1568574_x_at | |
Lung | 104 | 0.0122453 | 1.67 | Overall Survival | jacob-00182-MSK | 209875_s_at |
204 | 0.000247927 | 2.45 | Overall Survival | GSE31210 | 209875_s_at | |
204 | 3.04E-06 | 2.18 | Relapse Free Survival | GSE31210 | 209875_s_at | |
204 | 0.000616439 | 1.96 | Overall Survival | GSE31210 | 1568574_x_at | |
204 | 4.89E-05 | 1.77 | Relapse Free Survival | GSE31210 | 1568574_x_at | |
138 | 0.0119677 | 1.23 | Relapse Free Survival | GSE8894 | 209875_s_at | |
138 | 0.0214765 | 1.25 | Relapse Free Survival | GSE8894 | 1568574_x_at | |
129 | 0.0395 | 1.51 | Overall Survival | GSE4573 | 209875_s_at | |
Skin | 38 | 0.0434455 | 2.6 | Overall Survival | GSE19234 | 209875_s_at |